<--- Back to Details
First PageDocument Content
Medicine / Food and Drug Administration / Pharmacovigilance / Atomoxetine / Clinical trial / Hepatitis / Hepatitis C and HIV co-infection / Hepacivac / Pharmacology / Pharmaceutical sciences / Health
Date: 2014-09-18 02:21:33
Medicine
Food and Drug Administration
Pharmacovigilance
Atomoxetine
Clinical trial
Hepatitis
Hepatitis C and HIV co-infection
Hepacivac
Pharmacology
Pharmaceutical sciences
Health

Reporting Drug Side Effects

Add to Reading List

Source URL: www.hcvadvocate.org

Download Document from Source Website

File Size: 362,32 KB

Share Document on Facebook

Similar Documents

Web-Scale Pharmacovigilance: Listening to Signals from the Crowd Ryen W. White Ph.D.1*, Nicholas P. Tatonetti Ph.D.2, Nigam H. Shah M.B.B.S. Ph.D.3, Russ B. Altman M.D. Ph.D.4 and Eric Horvitz M.D. Ph.D.1 1 Microsoft Re

DocID: 1vpEW - View Document

Centre Anti Poison et de Pharmacovigilance du Maroc Société Marocaine de Toxicologie

DocID: 1v4Ie - View Document

Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU

DocID: 1uY7F - View Document

PREPARATION D’UN DIPLOME DE TOXICOLOGIE - PHARMACOVIGILANCE   

DocID: 1uOXD - View Document

Liste des inscrits à la formation de toxicologie pharmacovigilance Année 2005 – 2006 Module « Pharmacovigilance » Nom Abouali Fatima Achour Sanaa

DocID: 1uKFW - View Document